Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

4.91
-0.1900-3.73%
Post-market: 4.910.00000.00%16:04 EDT
Volume:1.16M
Turnover:5.77M
Market Cap:220.94M
PE:-2.26
High:5.19
Open:5.19
Low:4.86
Close:5.10
52wk High:54.97
52wk Low:4.01
Shares:45.00M
Float Shares:16.73M
Volume Ratio:1.12
T/O Rate:6.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1683
EPS(LYR):-1.8835
ROE:-32.34%
ROA:-21.54%
PB:0.83
PE(LYR):-2.61

Loading ...

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Jul 20

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Simply Wall St.
·
Jul 19

Sionna Therapeutics rises 9.2%

TIPRANKS
·
Jul 18

Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million

Reuters
·
Jul 10

Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick Disposes of 10,250 Common Shares Worth $446,862.08

Reuters
·
Jul 08

Orbimed Advisors Disposes of 115,844 Sionna Therapeutics Shares Worth $5.27 Million

Reuters
·
Jul 03

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Jun 25

Sionna Therapeutics: Buy Rating Reiterated on NBD1-Focused CF Strategy; $60 Price Target Maintained

TIPRANKS
·
Jun 22

Sionna Therapeutics shareholders elect Class II directors at annual meeting

Reuters
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 11

OrbiMed Advisors reports Sionna Therapeutics common stock sale valued at $4,493.49

Reuters
·
May 30

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences

GlobeNewswire
·
May 27

Sionna Therapeutics Price Target Maintained With a $63.00/Share by Citizens

Dow Jones
·
May 26

Stifel Nicolaus Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 25

Sionna Therapeutics Cut to Hold From Buy by Freedom Broker

Dow Jones
·
May 21

Sionna Therapeutics downgraded at Freedom Broker with unchanged target

TIPRANKS
·
May 20

Wedbush Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 18

Sionna Therapeutics price target raised to $55 from $44 at Stifel

TIPRANKS
·
May 18

LifeSci Capital Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 16

RBC Capital Sticks to Its Sell Rating for Sionna Therapeutics, Inc. (SION)

TIPRANKS
·
May 14